Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$9.00
-0.68-7.02%
Pre-Market: 9:24 AM EDT
Comments
Loading...
Mineralys Therapeutics Stock Price, Quotes and Forecasts
MLYSNASDAQ
Mineralys Therapeutics (MLYS) Forecast
NewsEarningsMineralys Therapeutics (MLYS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Mineralys Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:MLYS | Benzinga
Explore Mineralys Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MLYS.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Mineralys Therapeutics (MLYS) stock?
You can purchase shares of Mineralys Therapeutics (NASDAQ:MLYS) through any online brokerage.
Who are Mineralys Therapeutics (MLYS) competitors?
Other companies in Mineralys Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), KalVista Pharma (NASDAQ:KALV), Humacyte (NASDAQ:HUMA), Precigen (NASDAQ:PGEN) and Altimmune (NASDAQ:ALT).
What is the forecast, or price target, for Mineralys Therapeutics (MLYS) stock?
Mineralys Therapeutics has a consensus price target of $33.67.
What is the current price for Mineralys Therapeutics (MLYS)?
The stock price for Mineralys Therapeutics (NASDAQ: MLYS) is $9 last updated February 26, 2025 at 9:24 AM EST.
Does Mineralys Therapeutics (MLYS) pay a dividend?
There are no upcoming dividends for Mineralys Therapeutics.
When is Mineralys Therapeutics (NASDAQ:MLYS) reporting earnings?
Mineralys Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is Mineralys Therapeutics (MLYS) going to split?
There is no upcoming split for Mineralys Therapeutics.
What sector and industry does Mineralys Therapeutics (MLYS) operate in?
Mineralys Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.